Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Docetaxel (Taxotere) (NSC# 628503, IND# 59,761) in Children With Refractory Leukemias

NCT00021242 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00021242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00021242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Docetaxel (Taxotere) (NSC# 628503, IND# 59,761) in Children With Refractory Leukemias
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2002
Completion date
September 30, 2006
Enrollment
12 (actual)
Sites
228

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia